Willi K Born

Title: Willi K Born: Innovator in Airway Hyperresponsiveness Treatment

Introduction

Willi K Born is a notable inventor based in Denver, CO (US). He has made significant contributions to the field of medical research, particularly in the treatment of airway hyperresponsiveness. With a total of 3 patents to his name, Born's work focuses on innovative methods to improve respiratory health.

Latest Patents

One of his latest patents is a method to inhibit airway hyperresponsiveness using aerosolized T cell receptor antibodies. This method involves the direct delivery of aerosolized antibodies against T cell receptors to the lungs, effectively reducing airway hyperresponsiveness associated with allergic inflammation. It is particularly noteworthy for its effectiveness at extremely low doses of antibody and minimal impact on the peripheral immune system. Another significant patent by Born is related to the modulation of gamma delta T cells to regulate airway hyperresponsiveness. This patent discloses methods for regulating airway hyperresponsiveness by modulating the action of γδ T cells in patients, as well as identifying compounds that can influence this regulation.

Career Highlights

Throughout his career, Willi K Born has worked with esteemed organizations such as National Jewish Health and the National Jewish Medical and Research Center. His research has been pivotal in advancing the understanding and treatment of respiratory conditions.

Collaborations

Born has collaborated with notable colleagues, including Michael F Lahn and Arihiko Kanehiro, contributing to a rich exchange of ideas and innovations in his field.

Conclusion

Willi K Born's innovative approaches to treating airway hyperresponsiveness highlight his significant role in medical research. His patents reflect a commitment to improving patient outcomes through advanced therapeutic methods.